{
  "id": 2010,
  "text": "Of 22/25 patients post-treatment SCC-Ag data were available: 17/22 $( 7 7 \\% )$ had elevated SCC-Ag during follow-up.A raised SCC-Ag was observed before the clinical manifestation of recurrence in $4 3 \\%$ of cases whereas in $1 5 \\%$ of cases, the clinical recurrence preceded the SCC-Ag rise.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: Of 22/25 patients post-treatment SCC-Ag data were available: 17/22 $( 7 7 \\% )$ had elevated SCC-Ag during follow-up.A raised SCC-Ag was observed before the clinical manifestation of recurrence in $4 3 \\%$ of cases whereas in $1 5 \\%$ of cases, the clinical recurrence preceded the SCC-Ag rise.\n\n<question>: ",
  "ChatGPT_response_0": "在临床实践中，肿瘤标志物SCC-Ag的变化在77%的病例中可以先于复发的临床表现被观察到。其中，43%的病例在临床表现之前出现肿瘤标志物SCC-Ag的升高，而15%的病例则是临床表现先于肿瘤标志物SCC-Ag的升高。这表明SCC-Ag的变化可以在一部分病例中提前指示肿瘤的复发情况。",
  "query": "在临床实践中，肿瘤标志物SCC-Ag的变化在多大比例的病例中可以先于复发的临床表现被观察到？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 在临床实践中，肿瘤标志物SCC-Ag的变化在多大比例的病例中可以先于复发的临床表现被观察到？\n\n<reference text>: Of 22/25 patients post-treatment SCC-Ag data were available: 17/22 $( 7 7 \\% )$ had elevated SCC-Ag during follow-up.A raised SCC-Ag was observed before the clinical manifestation of recurrence in $4 3 \\%$ of cases whereas in $1 5 \\%$ of cases, the clinical recurrence preceded the SCC-Ag rise.\n\n<reply>: ",
  "response": "在临床实践中，肿瘤标志物SCC-Ag的变化在77%的病例中可以先于复发的临床表现被观察到。其中，43%的病例在临床表现之前出现肿瘤标志物SCC-Ag的升高，而15%的病例则是临床表现先于肿瘤标志物SCC-Ag的升高。这表明SCC-Ag的变化可以在一部分病例中提前指示肿瘤的复发情况。"
}